Comparison of efficacy of transcutaneous nerve stimulation and sensory discrimination education in patients with chronic low back pain

ISRCTN ISRCTN94184937
DOI https://doi.org/10.1186/ISRCTN94184937
Protocol serial number 3321; 078195
Sponsor Nuffield Orthopaedic Centre NHS Trust (UK)
Funder The Wellcome Trust (UK) (grant ref: 078195)
Submission date
31/03/2010
Registration date
31/03/2010
Last edited
03/12/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Jeremy C T Fairbank
Scientific

Old Road
Headington
Oxford
OX3 7LF
United Kingdom

Study information

Primary study designInterventional
Study designRandomised interventional single centre treatment trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleComparison of efficacy of transcutaneous nerve stimulation and sensory discrimination education in patients with chronic low back pain: a randomised interventional single centre treatment trial
Study objectivesThis is a comparison of transcutaneous nerve stimulation and sensory discrimination education in patients with chronic low back pain.
Ethics approval(s)Milton Keynes REC approved on the 2nd August 2005 (ref: 05/Q1603/34)
Health condition(s) or problem(s) studiedTopic: Musculoskeletal; Subtopic: Musculoskeletal (all Subtopics); Disease: Musculoskeletal
InterventionPatients aged greater than 18 years with greater than 3 months chronic low back pain awaiting physiotherapy at the Nuffield Orthopaedic Centre will be asked to complete one week of diary record of pain. An average of one week of diary record of pain by linear analogue scale will be the baseline measure of the primary outcome measure. Patients will be excluded if they complete the diary on less than 3 days during this week.
Intervention typeOther
Primary outcome measure(s)

0 - 100 mm Linear Analogue Pain Scale (LAS) for back pain, taken daily for one week recording best, worst and average. Outcome was based on mean score of 7 daily average scores.

Key secondary outcome measure(s)

1. Oswestry Disability Index
2. Euroqol
3. DRAM
4. An open questionnaire to assess satisfaction and comments on treatment.

Measured at baseline, 3 weeks, 6 weeks and 3 months.

Completion date01/01/2008

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexAll
Target sample size at registration54
Key inclusion criteria1. Chronic low back pain
2. Aged 18 years or older, either sex
Key exclusion criteria1. Aged less than 18 years
2. Treatment likely to harm patient
Date of first enrolment01/01/2006
Date of final enrolment01/01/2008

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Old Road
Oxford
OX3 7LF
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 28/06/2008 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes